Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 2.66 USD 1.92% Market Closed
Market Cap: $900.9m

Wall St Price Targets

GDRX Price Targets Summary
Goodrx Holdings Inc

Wall Street analysts forecast GDRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GDRX is 3.24 USD with a low forecast of 2.27 USD and a high forecast of 4.2 USD.

Lowest Forecast
Price Target
2.27 USD
15% Downside
Average Forecast
Price Target
3.24 USD
22% Upside
Highest Forecast
Price Target
4.2 USD
58% Upside
Goodrx Holdings Inc Competitors:
Price Targets
TDOC
Teladoc Health Inc
-10% Downside
4917
Mandom Corp
-35% Downside

Revenue
Forecast

22% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
22% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

22% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
22% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 3%.

Operating Income
Forecast

7% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-68%
Average Miss
7% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-68%
Average Miss

Over the last 8 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 31%.

Pre-Tax Income
Forecast

5% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 40%.

Net Income
Forecast

1% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 65%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GDRX's stock price target?
Price Target
3.24 USD

According to Wall Street analysts, the average 1-year price target for GDRX is 3.24 USD with a low forecast of 2.27 USD and a high forecast of 4.2 USD.

What is the Revenue forecast for Goodrx Holdings Inc?
Projected CAGR
4%

Over the last 8 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Goodrx Holdings Inc?
Projected CAGR
3%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 3%.

What is the Operating Income forecast for Goodrx Holdings Inc?
Projected CAGR
31%

Over the last 8 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 31%.

What is the Pre-Tax Income forecast for Goodrx Holdings Inc?
Projected CAGR
40%

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 40%.

What is the Net Income forecast for Goodrx Holdings Inc?
Projected CAGR
65%

Over the last 8 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 65%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett